Mckesson descreve o EPS ajustado fiscal de 2027 de $ 45,60-$ 46,40 ao fechar o negócio do US$ 2,25 bilhões Precision Med
"Second quarter revenues increased 8% with growth across all segments, while adjusted earnings per diluted share increased 18% year-over-year." (CEO & Chairman Brian Tyler)